Good morning, everyone, and welcome to Imunon's Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call. During to ...

Ten years after tailored radiotherapy (RT) for breast cancer, fewer than 3% of patients had locoregional recurrences (LRR), ...

Kujali is an AI-driven decision-support tool that delivers real-time clinical decision support to birth attendants.

An evolving understanding of the risks and benefits of HRT has led to a reevaluation of the role of HRT for breast cancer survivors.

A deep dive into how pharma funding shapes medical narratives, how the status quo perpetuates itself, and why science isn’t the meritocracy we imagine.

Joining me today are Sean McClain, Absci Corporation’s Founder and CEO; Zach Jonasson, Chief Financial Officer and Chief ...

Hello, and welcome to Wave Life Sciences Positive Interim Phase I Clinical Data from INLIGHT Trial of WVE-007 for Obesity Call. [Operator Instructions] Also, as a reminder, this conference is being ...

A 2026 report outlining Steel Power ingredient research, male enhancement supplement positioning, performance claim context, ...

There is a food that has been shown in multiple human randomized controlled trials to improve metabolic health, reduce liver ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. William Maguire discussing regulatory considerations related to PSMA PET imaging in clinical trials.

As a dietitian and diabetes educator, Kaitlin Hippley, M.Ed., RDN, LD, CDCES, says one myth she hears all the time is that ...